Evidence map›Paper›PMID 29099085›Full record

ArticleInternational journal of molecular sciences2017

Eburicoic Acid, a Triterpenoid Compound from Antrodia camphorata, Displays Antidiabetic and Antihyperlipidemic Effects in Palmitate-Treated C2C12 Myotubes and in High-Fat Diet-Fed Mice.

Cheng-Hsiu Lin, Yueh-Hsiung Kuo, Chun-Ching Shih

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Evidence-Based Nutraceuticals Derived fromFoods (Basel, Switzerland) · 2025
    Review
  7. Research on the Action and Mechanism of Pharmacological Components ofInternational journal of molecular sciences · 2024
    Review
  8. Article
  9. Review
  10. Protective Effect ofNutrients · 2023
    Article
  11. Antidiabetic and Immunoregulatory Activities of Extract ofInternational journal of molecular sciences · 2023
    Article
  12. Metabolomic Profiling of DifferentJournal of fungi (Basel, Switzerland) · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Medicina (Kaunas, Lithuania) · 2019
    Article
  17. Triterpenoids fromMolecules (Basel, Switzerland) · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Cheng-Hsiu LinDepartment of Internal Medicine, Fengyuan Hospital, Ministry of Health and Welfare, Fengyuan District, Taichung City 42055, Taiwan. keny71@pchome.com.tw.
Yueh-Hsiung KuoDepartment of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung City 40402, Taiwan. kuoyh@mail.cmu.edu.tw.ORCID 0000-0001-5935-6755
Chun-Ching ShihGraduate Institute of Biotechnology and Biomedical Engineering, College of Health Science, Central Taiwan University of Science and Technology, No.666 Buzih Road, Beitun District, Taichung City 40601, Taiwan. ccshih@ctust.edu.tw.ORCID 0000-0003-4264-2602
Asia University · TWCentral Taiwan University of Science and Technology · TWMinistry of Health and Welfare · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study was designed to investigate the antidiabetic and antihyperlipidemic effects and mechanisms of eburicoic acid (TRR); one component of

Indexed as

AnimalsAntrodiaBlood GlucoseCell LineDiabetes Mellitus, ExperimentalDiet, High-FatFatty AcidsGlucose Transporter Type 4HyperlipidemiasHypoglycemic AgentsHypolipidemic AgentsInsulinLanosterolMiceMice, Inbred C57BLMice, Inbred ICRBlood Glucoseeburicoic acidFatty AcidsGlucose Transporter Type 4Hypoglycemic AgentsHypolipidemic AgentsInsulinLanosterolPalmitatesTriglyceridesAntrodia camphoratadiabeteseburicoic acidfatty acid synthaseforkhead box protein O1peroxisome proliferator-activated receptor α

Identifiers

PMID29099085
PMCPMC5713283
OpenAlexW2765590178

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.